MEDOS INTERNATIONAL SARL

Manufacturer adverse-event records for MEDOS INTERNATIONAL SARL come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2015–2026 · mid-book · typical Death-code · balanced

Death-code intensity

MEDOS INTERNATIONAL SARL tracks a typical Death-code share

Death-coded event_type rows are 86 of 12,873 (0.67% · typical tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for MEDOS INTERNATIONAL SARL

The standout signal for MEDOS INTERNATIONAL SARL is Death-code intensity: 0.67% of 12,873 reports (typical tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for MEDOS INTERNATIONAL SARL. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 10,995 (85.4% of event_type total). Peak single-year volume reaches 2,369 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

12,873
Total Reports
86
Event-type Death
1,791
Injury Reports
20
Device Types

Event Types

Malfunction 10,995 (85.4%)
Injury 1,791 (13.9%)
Death 86 (0.7%)
1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

10,844 (83.6%)
Required Intervention 1,047 (8.1%)
Life Threatening 401 (3.1%)
R 174 (1.3%)
Other 159 (1.2%)
Hospitalization 95 (0.7%)
L 84 (0.6%)
Death 82 (0.6%)
H 41 (0.3%)
S 31 (0.2%)
Disability 8 (0.1%)
D 6 (0.0%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

15
2015: 55
16
2016: 372
17
2017: 364
18
2018: 189
19
2019: 494
20
2020: 876
21
2021: 1,978
22
2022: 2,369
23
2023: 1,866
24
2024: 1,998
25
2025: 1,916
26
2026: 396